Details

Autor(en) / Beteiligte

• Mardinoglu, Adil
• Agren, Rasmus
• Kampf, Caroline
• Asplund, Anna
• Nookaew, Intawat
• Jacobson, Peter
• Walley, Andrew J
• Froguel, Philippe
• Carlsson, Lena M
• Uhlen, Mathias
• Nielsen, Jens

Titel

Integration of clinical data with a genome‐scale metabolic model of the human adipocyte

Ist Teil von

• Molecular systems biology, 2013, Vol.9 (1), p.649-n/a

Ort / Verlag

Chichester, UK: John Wiley & Sons, Ltd

Erscheinungsjahr

2013

Quelle

Elektronische Zeitschriftenbibliothek

Beschreibungen/Notizen

• We evaluated the presence/absence of proteins encoded by 14 077 genes in adipocytes obtained from different tissue samples using immunohistochemistry. By combining this with previously published adipocyte‐specific proteome data, we identified proteins associated with 7340 genes in human adipocytes. This information was used to reconstruct a comprehensive and functional genome‐scale metabolic model of adipocyte metabolism. The resulting metabolic model, iAdipocytes1809, enables mechanistic insights into adipocyte metabolism on a genome‐wide level, and can serve as a scaffold for integration of omics data to understand the genotype–phenotype relationship in obese subjects. By integrating human transcriptome and fluxome data, we found an increase in the metabolic activity around androsterone, ganglioside GM2 and degradation products of heparan sulfate and keratan sulfate, and a decrease in mitochondrial metabolic activities in obese subjects compared with lean subjects. Our study hereby shows a path to identify new therapeutic targets for treating obesity through combination of high throughput patient data and metabolic modeling. Combining large‐scale immunohistochemical analysis and proteomics data, 7340 gene products are identified in human adipocytes. Based on this data, a genome‐scale metabolic model is reconstructed and used to integrate clinical and transcriptome data from lean and obese subjects. Synopsis Combining large‐scale immunohistochemical analysis and proteomics data, 7340 gene products are identified in human adipocytes. Based on this data, a genome‐scale metabolic model is reconstructed and used to integrate clinical and transcriptome data from lean and obese subjects. We simulated the metabolic differences between the individuals with different body mass indexes (BMIs) using transcriptome and fluxome data. An increase in the metabolic activity around androsterone, ganglioside GM2 and degradation products of heparan sulfate and keratan sulfate, and a decrease in mitochondrial metabolic activities are found in obese subjects compared with lean subjects. We simulated the change in lipid droplet (LD) size and found that lean subjects have large dynamic changes in LD formation compared with obese subjects. Besides enabling patient stratification, our study allows the identification of novel therapeutic targets for obesity.